Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study

Haematologica. 2018 Sep;103(9):e412-e415. doi: 10.3324/haematol.2017.183475. Epub 2018 Mar 22.

Sigrun Thorsteinsdottir^{1

2}, Paul W Dickman³, Ola Landgren⁴, Cecilie Blimark⁵, Malin Hultcrantz^{4

6}, Ingemar Turesson⁷, Magnus Björkholm⁶, Sigurdur Y Kristinsson^{8

2

6}

¹ Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.
² Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
³ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁴ Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, NY, USA.
⁵ Department of Internal Medicine, Hematology Section, Sahlgrenska University Hospital, Gothenburg, Sweden.
⁶ Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
⁷ Department of Hematology and Coagulation Disorders, Skane University Hospital, Malmo, Sweden.
⁸ Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland sigyngvi@hi.is.

No abstract available

Publication types